INJ PAN IV,SUMO L IV INFUSION 100ML,INJ NOR ADRENALIN 2 ML,INJ XYLOCAINE 2,INJ CALCIUM GLUCONATE,IN
Border Security Force (bsf)
FIROZPUR, PUNJAB
Bid Publish Date
22-Apr-2025, 11:28 am
Bid End Date
22-May-2025, 12:00 pm
Location
Progress
RAQuantity
790644
Bid Type
Two Packet Bid
N/a invites bids for Inj Amino Acids, Inj Ciprofloxacin, Inj Compound Sodium Lactate Solution, Inj Dextrose 5 percent, Inj Dextrose 10percent 500ml, Inj Dextrose 25percent 100ml, Inj Dextrose 50percent 100ml, Inj Dextrose 5percent, Distilled Water 5 Ltr Can, Inj Fat Emulsion 10percent 500 ml, Inj Fluconazole 200 mg, Inj Haemaccel 500 ml, Inj Albumin 20percent 50 ml, Inj Albumin 20percent 100 ml, Inj Immunoglobulin 5 gm per 100 ml, Inj Hydroxyl Ethyl Starch 6percent, Inj Linezolid 600 mg, Inj Levofloxacin 500 mg, Inj Mannitol 20percent, Inj Metronidazole 500 mg, Paediatric maintenance infusion, Inj Ofloxacin, Inj Paracetamol Infusion 1000 mg, Inj Sodium Chloride, Inj Sodium Cloride 3percent 250 ml, Inj 3 in 1 TPN 1000 ml, Inj Isotonic Electrolyte Solution Lactate Free 500 ml, Sterile Water for Inj 500 ml, Potassium free Hemodialysis fluid 5L, Haemodialysis Fluid Part A 5l for HD Machine, Calcium free Hemodialysis FLUID 5L, Bicarb Powder part B for HD machine, Haemodialysis Fluid in CENTRAL DELHI, DELHI. Quantity: 790644. Submission Deadline: 22-05-2025 12: 00: 00. Submit your proposal before the deadline.
Main Document
BOQ
BOQ
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Border Security Force (bsf)
FIROZPUR, PUNJAB
Indian Army
TINSUKIA, ASSAM
Indian Army
RAJAURI, JAMMU & KASHMIR
N/a
BANGALORE, KARNATAKA
Swami Vivekanand National Institute Of Rehabilitation Training And Research (svnirtar)
CUTTACK, ODISHA
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Inj Amino Acids | as per specifications | 5,040 | nos | vivek12 | 365 |
| 2 | Inj Ciprofloxacin | as per specifications | 8,040 | nos | vivek12 | 365 |
| 3 | Inj Compound Sodium Lactate Solution | as per specifications | 150,000 | nos | vivek12 | 365 |
| 4 | Inj Dextrose 5 percent | as per specifications | 60,000 | nos | vivek12 | 365 |
| 5 | Inj Dextrose 10percent 500ml | as per specifications | 8,040 | nos | vivek12 | 365 |
| 6 | Inj Dextrose 25percent 100ml | as per specifications | 40,200 | nos | vivek12 | 365 |
| 7 | Inj Dextrose 50percent 100ml | as per specifications | 1,500 | nos | vivek12 | 365 |
| 8 | Inj Dextrose 5percent | as per specifications | 8,040 | nos | vivek12 | 365 |
| 9 | Distilled Water 5 Ltr Can | as per specifications | 4,020 | nos | vivek12 | 365 |
| 10 | Inj Fat Emulsion 10percent 500 ml | as per specifications | 204 | nos | vivek12 | 365 |
| 11 | Inj Fluconazole 200 mg | as per specifications | 4,020 | nos | vivek12 | 365 |
| 12 | Inj Haemaccel 500 ml | as per specifications | 156 | nos | vivek12 | 365 |
| 13 | Inj Albumin 20percent 50 ml | as per specifications | 8,040 | nos | vivek12 | 365 |
| 14 | Inj Albumin 20percent 100 ml | as per specifications | 5,040 | nos | vivek12 | 365 |
| 15 | Inj Immunoglobulin 5 gm per 100 ml | as per specifications | 9,000 | nos | vivek12 | 365 |
| 16 | Inj Hydroxyl Ethyl Starch 6percent | as per specifications | 804 | nos | vivek12 | 365 |
| 17 | Inj Linezolid 600 mg | as per specifications | 15,000 | nos | vivek12 | 365 |
| 18 | Inj Levofloxacin 500 mg | as per specifications | 15,000 | nos | vivek12 | 365 |
| 19 | Inj Mannitol 20percent | as per specifications | 15,000 | nos | vivek12 | 365 |
| 20 | Inj Metronidazole 500 mg | as per specifications | 120,000 | nos | vivek12 | 365 |
| 21 | Paediatric maintenance infusion | as per specifications | 4,020 | nos | vivek12 | 365 |
| 22 | Inj Ofloxacin | as per specifications | 600 | nos | vivek12 | 365 |
| 23 | Inj Paracetamol Infusion 1000 mg | as per specifications | 120,000 | nos | vivek12 | 365 |
| 24 | Inj Sodium Chloride | as per specifications | 60,000 | nos | vivek12 | 365 |
| 25 | Inj Sodium Cloride 3percent 250 ml | as per specifications | 5,040 | nos | vivek12 | 365 |
| 26 | Inj Sodium Chloride | as per specifications | 12,000 | nos | vivek12 | 365 |
| 27 | Inj 3 in 1 TPN 1000 ml | as per specifications | 2,520 | nos | vivek12 | 365 |
| 28 | Inj Isotonic Electrolyte Solution Lactate Free 500 ml | as per specifications | 15,000 | nos | vivek12 | 365 |
| 29 | Sterile Water for Inj 500 ml | as per specifications | 20,040 | nos | vivek12 | 365 |
| 30 | Potassium free Hemodialysis fluid 5L | as per specifications | 1,020 | ltr | vivek12 | 365 |
| 31 | Haemodialysis Fluid Part A 5l for HD Machine | as per specifications | 1,020 | ltr | vivek12 | 365 |
| 32 | Calcium free Hemodialysis FLUID 5L | as per specifications | 1,020 | ltr | vivek12 | 365 |
| 33 | Bicarb Powder part B for HD machine | as per specifications | 1,020 | ltr | vivek12 | 365 |
| 34 | Haemodialysis Fluid | as per specifications | 70,200 | ltr | vivek12 | 365 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
12-Oct-2025, 2:00 pm
End
17-Oct-2025, 10:00 am
Duration: 116 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 21-05-2025 19:38:30 | Evaluated |
| 2 | ********** Under PMA | - | 21-05-2025 22:18:39 | Evaluated |
| 3 | ********** Under PMA | - | 16-05-2025 17:39:01 | Evaluated |
| 4 | ********** Under PMA | - | 21-05-2025 23:08:45 | Evaluated |
| 5 | ********** Under PMA | - | 21-05-2025 11:33:28 | Evaluated |
| 6 | ********** Under PMA | - | 20-05-2025 19:31:24 | Evaluated |
| 7 | ********** Under PMA | - | 17-05-2025 14:15:38 | Evaluated |
| 8 | ********** Under PMA | - | 17-05-2025 13:02:50 | Evaluated |
| 9 | ********** Under PMA | - | 21-05-2025 22:39:59 | Evaluated |
| 10 | ********** Under PMA | - | 21-05-2025 15:41:01 | Evaluated |
| 11 | ********** Under PMA | - | 21-05-2025 16:55:54 | Evaluated |
| 12 | ********** Under PMA | - | 22-05-2025 10:05:29 | Evaluated |
| 13 | ********** Under PMA | - | 21-05-2025 17:07:55 | Evaluated |
| 14 | ********** Under PMA | - | 21-05-2025 16:50:57 | Evaluated |
| 15 | ********** Under PMA | - | 22-05-2025 09:43:51 | Evaluated |
| 16 | ********** Under PMA | - | 17-05-2025 13:39:14 | Evaluated |
| 17 | ********** Under PMA | - | 22-05-2025 11:27:47 | Evaluated |
| 18 | ********** Under PMA | - | 22-05-2025 11:13:49 | Evaluated |
| 19 | ********** Under PMA | - | 21-05-2025 18:07:08 | Evaluated |
| 20 | ********** Under PMA | - | 26-04-2025 12:21:32 | Evaluated |
Please sign in or create an account to view contract details and download result documents.
Key insights about DELHI tender market
The eligibility requirements include being a registered entity capable of supplying injectable medications, having relevant authorizations for pharmaceutical distribution, and providing documentation of experience in similar supplies. Compliance with regulatory standards set by the Ministry of Health and Family Welfare is mandatory. Entities should demonstrate their capability and reliability in delivering high-quality products to healthcare facilities.
Bidders are required to possess and provide valid certifications, including:
All required documents must be submitted electronically through the designated tendering portal. Bidders should ensure that their submissions are in acceptable formats, primarily PDF or Word. It's crucial to include all necessary documentation, including technical specifications and financial statements, to meet the submission requirements effectively.
The Earnest Money Deposit (EMD) protects against bid withdrawals and defaults. The specific amount will be stipulated in the tender notice. Bidders are typically required to submit the EMD along with their proposals, which will be refunded upon finalization of the contract. MSEs and startups may enjoy exemptions from this requirement.
MSEs participating in this tender may benefit from specific provisions that promote inclusivity within the procurement process. Benefits may include exemptions from the EMD, a preferential evaluation process, and support for local sourcing as per the government’s initiatives like 'Make in India'. These measures encourage MSEs to contribute to the health sector by supplying essential medicines.
Sign up now to access all documents
Main Document
BOQ
BOQ
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS